Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Olsson

Showing results (301-310 of 890) with videos related to

Pageof 89
Sort By:
World Journal of Urology|January 1, 1996
Absorbable stapling techniques in continent urinary diversionA J Kirsch, T W Hensle, C A Olsson
The Journal of Urology|August 1, 1996
Pediatric continent reservoirs and colocystoplasty created with absorbable staplesA J Kirsch, C A Olsson, T W Hensle
The Journal of Urology|May 1, 1996
The ileal ureter neobladder is associated with a high success and a low complication rateM C Benson, E K Seaman, C A Olsson
European Urology|January 1, 1995
Terazosin and doxazosin in normotensive men with symptomatic prostatism: a pilot study to determine the effect of dosing regimen on efficacy and safetyS A Kaplan, K A Soldo, C A Olsson
BMC Research Notes|September 16, 2014
Renal function is a determinant of subjective well-being in active seniors but not in patients with subjective memory complaintsLovisa A Olsson, Nils-Olof Hagnelius, Torbjörn K Nilsson
British Journal of Urology|April 1, 1988
The limited usefulness of external beam radiotherapy in the control of superficial bladder cancerI S Sawczuk, C A Olsson, R deVere White
Mutagenesis|August 26, 1998
Mitotic disturbance by carbaryl and the metabolite 1-naphthol may involve kinase-mediated phosphorylation of 1-naphthol to the protein phosphatase inhibitor 1-naphthylphosphateA Renglin, A Olsson, C A Wachtmeister, et al.
Urology|July 1, 1973
Seminal vesicle amyloidosisR J Krane, R C Klugo, C A Olsson
Advances in Experimental Medicine and Biology|January 1, 1973
Myocardial: blood purine nucleoside concentration ratios in canine myocardiumJ A Snow, R A Olsson, M K Gentry
Anticancer Research|December 31, 1997
Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agentsT Dorai, E T Goluboff, C A Olsson, et al.
Pageof 89

Showing results (301-310 of 890) with videos related to

Sort By:
Pageof 89
World Journal of Urology|January 1, 1996
Absorbable stapling techniques in continent urinary diversionA J Kirsch, T W Hensle, C A Olsson
The Journal of Urology|August 1, 1996
Pediatric continent reservoirs and colocystoplasty created with absorbable staplesA J Kirsch, C A Olsson, T W Hensle
The Journal of Urology|May 1, 1996
The ileal ureter neobladder is associated with a high success and a low complication rateM C Benson, E K Seaman, C A Olsson
European Urology|January 1, 1995
Terazosin and doxazosin in normotensive men with symptomatic prostatism: a pilot study to determine the effect of dosing regimen on efficacy and safetyS A Kaplan, K A Soldo, C A Olsson
BMC Research Notes|September 16, 2014
Renal function is a determinant of subjective well-being in active seniors but not in patients with subjective memory complaintsLovisa A Olsson, Nils-Olof Hagnelius, Torbjörn K Nilsson
British Journal of Urology|April 1, 1988
The limited usefulness of external beam radiotherapy in the control of superficial bladder cancerI S Sawczuk, C A Olsson, R deVere White
Mutagenesis|August 26, 1998
Mitotic disturbance by carbaryl and the metabolite 1-naphthol may involve kinase-mediated phosphorylation of 1-naphthol to the protein phosphatase inhibitor 1-naphthylphosphateA Renglin, A Olsson, C A Wachtmeister, et al.
Urology|July 1, 1973
Seminal vesicle amyloidosisR J Krane, R C Klugo, C A Olsson
Advances in Experimental Medicine and Biology|January 1, 1973
Myocardial: blood purine nucleoside concentration ratios in canine myocardiumJ A Snow, R A Olsson, M K Gentry
Anticancer Research|December 31, 1997
Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agentsT Dorai, E T Goluboff, C A Olsson, et al.
Pageof 89